Dan Peer

Last updated
Portrait of Dan Peer Dan Peer.jpg
Portrait of Dan Peer

Dan Peer is a Professor and the Director of the Laboratory of Precision NanoMedicine at Tel Aviv University (TAU). He is also the Vice President for Research and Development at TAU. In 2017 he co-founded and acts as the managing director of SPARK Tel Aviv, Center for Translational Medicine. From 2016–2020 he was the chair of the TAU Cancer Biology Research Center. [1]

Contents

Peer is a scientific advisory board member in more than 15 companies and on the scientific advisory board of 20 journals. He is a past President of the Israeli Chapter of the Controlled Release Society. [2] In 2014 he was elected to the Israel Young Academy of Science. [3] In 2023 he was elected to the US National Academy of Engineering.

Research work

Prof. Peer pioneered the field of active cellular targeting of RNA payloads into specific cell types. His lab was among the first to demonstrate immunomodulation through a systemic delivery of RNA-loaded targeted nanocarriers. The team also pioneered the use of RNAi to reprogram immune cells and discover new therapeutic modalities. [4] In addition, his lab was the first to show systemic, cell specific delivery of mRNA in an animal. Through this approach they have induced therapeutic gene expression of desired proteins (including novel approaches for cell specific, high efficiency therapeutic genome editing), which has implications in cancer, rare genetic diseases and infectious diseases. [5] [6] Recently, the Peer lab was the first to develop a bacterial mRNA vaccine, which could provide a fast response against an aggressive bacterial infection and antibiotic resistant strains. Furthermore, the team is developing novel therapeutic strategies to treat different types of cancers using novel drug targets that they identify, cancer vaccines or by using bacterial toxins in the form of mRNA to kill tumor cells. [7]

On top of this, the Peer lab generated a very large lipid library with unique features. Some of these lipids have been licensed to several major pharmaceutical companies and are now under clinical development as carriers for siRNA, mRNA, and circRNA for different indications including cancer, infectious diseases, rare genetic diseases and inflammation. [8] [9] [10]

Awards

Partial list:

Related Research Articles

<span class="mw-page-title-main">Ruth Arnon</span> Israeli biochemist

Ruth Arnon is an Israeli biochemist and codeveloper of the multiple sclerosis drug Copaxone. She is currently the Paul Ehrlich Professor of Immunology at the Weizmann Institute of Science, where she is researching anti-cancer and influenza vaccinations.

<span class="mw-page-title-main">Eva Feldman</span> American neurologist

Eva Lucille Feldman, M.D., Ph.D., F.A.A.N., F.A.N.A. is an American physician-scientist and one of the world’s leading authorities on neurodegenerative disease. Currently, she serves as the Russell N. DeJong Professor of Neurology at the University of Michigan, as well as Director of the NeuroNetwork for Emerging Therapies and ALS Center of Excellence at Michigan Medicine. She was also recently named the James W. Albers Distinguished University Professor of Neurology.

<span class="mw-page-title-main">Karen Avraham</span> Israeli geneticist

Karen B. Avraham is an Israeli-American human geneticist and the first female Dean of the Tel Aviv University's Faculty of Medicine. Born in Canada in 1962, Avraham moved to the US at a young age. Her research focuses on the discovery and characterization of genes responsible for hereditary hearing loss.

Nahum Sonenberg, is an Israeli Canadian microbiologist and biochemist. He is a James McGill professor of biochemistry at McGill University in Montreal, Quebec, Canada. He was an HHMI international research scholar from 1997 to 2011 and is now a senior international research scholar. He is best known for his seminal contributions to our understanding of translation, and notable for the discovery of the mRNA 5' cap-binding protein, eIF4E, the rate-limiting component of the eukaryotic translation apparatus.

<span class="mw-page-title-main">Ehud Gazit</span> Israeli biochemist and nanotechnologist

Ehud Gazit is an Israeli biochemist, biophysicist and nanotechnologist. He is Professor and Endowed Chair at Tel Aviv University and a member of the executive board of the university. In 2015, he was knighted by the Italian Republic for services to science and society. He was recently elected as the 2023 International Solvey Chair in Chemistry, a position that was previously held by 15 of the top world scientists including three Nobel laureates.

<span class="mw-page-title-main">Sangeeta N. Bhatia</span> American nanotechnologist

Sangeeta N. Bhatia is an American biological engineer and the John J. and Dorothy Wilson Professor at MIT’s Institute for Medical Engineering and Science and Electrical Engineering and Computer Science (EECS) at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, United States. Bhatia's research investigates applications of micro- and nano-technology for tissue repair and regeneration. She applies ideas from computer technology and engineering to the design of miniaturized biomedical tools for the study and treatment of diseases, in particular liver disease, hepatitis, malaria and cancer.

<span class="mw-page-title-main">Aviv Regev</span> Bioinformatician

Aviv Regev is a computational biologist and systems biologist and Executive Vice President and Head of Genentech Research and Early Development in Genentech/Roche. She is a core member at the Broad Institute of MIT and Harvard and professor at the Department of Biology of the Massachusetts Institute of Technology. Regev is a pioneer of single cell genomics and of computational and systems biology of gene regulatory circuits. She founded and leads the Human Cell Atlas project, together with Sarah Teichmann.

<span class="mw-page-title-main">Hermona Soreq</span> Israeli biologist

Hermona Soreq is an Israeli professor of Molecular Neuroscience at The Hebrew University of Jerusalem. Best known for her work on the signaling of acetylcholine and its relevance in stress responses and neurodegenerative diseases such as Parkinson's and Alzheimer's.

Jorge Enrique Galán is an Argentinian-American microbiologist who specializes in infectious disease, bacterial pathogenesis including Salmonella.

<span class="mw-page-title-main">Lynne E. Maquat</span> American biochemist

Lynne Elizabeth Maquat is an American biochemist and molecular biologist whose research focuses on the cellular mechanisms of human disease. She is an elected member of the American Academy of Arts and Sciences, the National Academy of Sciences and the National Academy of Medicine. She currently holds the J. Lowell Orbison Endowed Chair and is a professor of biochemistry and biophysics, pediatrics and of oncology at the University of Rochester Medical Center. Professor Maquat is also Founding Director of the Center for RNA Biology and Founding Chair of Graduate Women in Science at the University of Rochester.

<span class="mw-page-title-main">Feng Zhang</span> Chinese-American biochemist

Feng Zhang is a Chinese-American biochemist. Zhang currently holds the James and Patricia Poitras Professorship in Neuroscience at the McGovern Institute for Brain Research and in the departments of Brain and Cognitive Sciences and Biological Engineering at the Massachusetts Institute of Technology. He also has appointments with the Broad Institute of MIT and Harvard. He is most well known for his central role in the development of optogenetics and CRISPR technologies.

<span class="mw-page-title-main">Stephen Jackson (biologist)</span> British biologist

Sir Stephen Philip Jackson, FRS, FMedSci is the Frederick James Quick Professor of Biology. He is a Senior Group Leader at the Cancer Research UK Cambridge Institute and Associate Group Leader at the Gurdon Institute, University of Cambridge.

Ido Bachelet is an Israeli scientist.

<span class="mw-page-title-main">Don W. Cleveland</span>

Don W. Cleveland is an American cancer biologist and neurobiologist.

<span class="mw-page-title-main">Tony Jun Huang</span>

Tony Jun Huang is the William Bevan Distinguished Professor of Mechanical Engineering and Materials Science at Duke University.

Michael Karin is an Israeli-American Distinguished Professor of Pharmacology, Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases, American Cancer Society Research Professor at the University of California, San Diego.

Joy Wolfram is a Finnish nanoscientist. She is known for her pioneering work in nanomedicine concerning the treatment of cancer, cardiovascular diseases and other life-threatening illnesses. She is an Associate Professor at the University of Queensland, in the school of Chemical Engineering and the Australian Institute for Bioengineering and Nanotechnology. She was the forefront of the Extracellular Vesicles and Nanomedicine laboratory at Mayo Clinic. She is also an affiliate faculty member at Houston Methodist Hospital's Department of Nanomedecine. Wolfram sits as a scientific advisor and as a board member of several biotechnology companies around the world.

<span class="mw-page-title-main">Uğur Şahin</span> German oncologist and immunologist (born 1965)

Uğur Şahin is a German oncologist and immunologist. He is the founder and CEO of BioNTech, which developed one of the major vaccines against COVID-19. His main fields of research are cancer research and immunology.

<span class="mw-page-title-main">Bob Löwenberg</span>

Bob Löwenberg is a clinical hematologist/investigator. He is Professor of Hematology at Erasmus University Rotterdam.

<span class="mw-page-title-main">Tamir Tuller</span> Israeli researcher

Tamir Tuller is an Israeli engineer, a computer scientist, and a systems and synthetic biologist. He is a professor and the director of Tel Aviv University's Laboratory of Computational Systems and Synthetic Biology. As of February 2022, Tuller has authored over 150 peer-reviewed scientific journal articles and hundreds of additional types of publications and patents. In addition, he is the founder and primary instructor of the International Genetically Engineered Machine program at Tel Aviv University and an entrepreneur.

References

  1. "Dan Peer Lab, Tel Aviv University - Prof. Dan Peer". Tel Aviv University.
  2. "Dan Peer". Controlled Release Society (CRS).
  3. "TAU professor appointed to Young Academy of Science". Tel Aviv University. 14 May 2014.
  4. "Beyin kanseri tedavisinde büyük buluş". Şalom (in Turkish).
  5. "New platform based on biology and nanotechnology carries mRNA directly to target cells". Phys.org.
  6. "TAU sets up translational medical research center". Globes (in Hebrew). 30 January 2018.
  7. Shamah, David. "Nano-bullet tech shoots down brain cancer in Tel Aviv U study". The Times of Israel.
  8. Arnold, Janice (5 March 2019). "Cannabis to treat cancer? Israeli scientist thinks so". The Canadian Jewish News.
  9. "Dan Peer: "Mi trabajo es ciencia ficción: trato de hacer realidad ideas locas "". La Nación (in Spanish). 19 August 2019.
  10. "Researchers divided on future of cannabis as a whole plant or isolated medicine". Daily Hive.
  11. "The Kenneth Rainin Foundation 2010 Innovator Awards". Kenneth Rainin Foundation.
  12. "Recipients 2013". Kenneth Rainin Foundation.